RxAssist
  • Patients
  • Health professionals
  • Programs
  • Discount card
  • FAQs
  • Patients
  • Health professionals
  • Programs
  • Discount card
  • FAQs
  • About us
  • Contact
RxAssist

Find free and low-cost medication programs, and the forms to apply.

Find help

  • Search programs
  • Program directory
  • Prescription savings card
  • Patient resources

Guides

  • For patients
  • For health professionals
  • FAQs

RxAssist

  • About us
  • Contact
  • Privacy
  • Terms of use

This information is for informational purposes only and is not meant to be a substitute for professional medical advice, diagnosis, or treatment. Neither RxAssist nor RxVantage is offering advice, recommending, or endorsing any specific prescription drug, pharmacy, or other information on the site. Neither RxVantage nor RxAssist provides any warranty for any of the pricing data or other information. Please seek medical advice before starting, changing, or terminating any medical treatment. Third-party logos, trademarks, brand names, and images contained on rxassist.org or rxvantage.com are for demonstration purposes only. They are owned by their respective rights holders, who are not affiliated with this Site.

Copyright © 2026, RxVantage, all rights reserved.

ASTRAZENECA PHARMACEUTICALS

AZ & Me Prescription Savings Program for people without insurance

Information last checked September 22, 2026

Contact info

Phone
1-800-292-6363
Fax
1-877-239-0876
Website
AZ & Me Website (opens in a new tab)

Eligibility

  • Visit AZ&Me website to apply online or to download an application.
  • Patients must meet qualifying income eligibility criteria.
  • Patient must be a resident of the US.
  • Patient must not have prescription drug coverage under a private insurance or government program, or receiving any other assistance to help pay for medicine.
  • Patients who have experienced a life changing event in the past year are encouraged to apply for the AZ&Me Prescription Savings Program. Examples of this type of event include: Loss of employment, Change in income, Loss of, or change in, prescription drug coverage, Marriage or Change in household number.
  • NOTE: Effective May 1, 2026, the AZ&Me program will no longer accept new patients for FARXIGA and XIGDUO XR. Actively enrolled patients will continue to receive assistance for FARXIGA and XIGDUO XR until December 31, 2026
Income limit, single
Not published
Income limit, couple
Not published
Other income rules
  • For Specialty and Primary products, annual adjusted gross income must be at or below 300% of the Federal Poverty Level.
  • For Rare Disease product(s), (WAINUA) your annual adjusted gross income must be at or below 500% of the Federal Poverty Level.
Medical expenses can be deducted
Not published
Social Security number asked for
No
US citizenship or residency required
Yes

Not sure where your income falls? See this year's federal poverty guidelines (opens in a new tab).

Application process

Documents to attach
  • Proof of income
  • Prescription
Prescriber license number
  • NPI number
  • State license number
Who can sign
Physician
Application can be faxed
Yes
Decision letter sent to
Providers receive a fax, patient receives letter and phone call

Getting the medication

Patient receives
Medication
Shipped to
Provider. To get medication delivered directly to the patient's home the following must be written on the prescription - Ship to patient's address: (then put address)
Supply per shipment
Varies by product
Time to first delivery
0–2 weeks
Refills
Refills can be requested by calling the Program
Staying enrolled
  • New application every 12 months
  • New proof of income every 12 months
  • New prescription every 12 months

Medications covered

  • Airsupra (albuterol/budesonide)
  • Baxfendy (baxdrostat)
  • Bevespi Aerosphere (glycopyrrolate and formoterol fumarate)
  • Breztri Aerosphere inhalation aerosol (budesonide/glycopyrrolate/formoterol fumarate)
  • Calquence (acalabrutinib)
  • Fasenra (benralizumab)
  • Fasenra Pen (benralizumab)
  • Imfinzi (durvalumab)
  • Imjudo (tremelimumab-actl)
  • Lokelma (sodium zirconium cyclosilicate)
  • Lynparza Capsule (olaparib)
  • Saphnelo (anifrolumab-fnia)
  • Tagrisso (osimertinib)
  • Truqap (capivasertib)
  • Wainua (eplontersen)

Application forms & instructions

This program doesn't publish a form. Call or visit the program website to apply.